Literature DB >> 10790438

Clinical use of antenatal corticosteroids: benefits and risks.

J D Merrill1, R A Ballard.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 10790438     DOI: 10.1542/neo.1-5-e91

Source DB:  PubMed          Journal:  Pediatr Rev        ISSN: 0191-9601


× No keyword cloud information.
  2 in total

1.  Antenatally administered PPAR-gamma agonist rosiglitazone prevents hyperoxia-induced neonatal rat lung injury.

Authors:  Virender K Rehan; Reiko Sakurai; Julia Corral; Melissa Krebs; Basil Ibe; Kaori Ihida-Stansbury; John S Torday
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-08-20       Impact factor: 5.464

Review 2.  Minireview: the impact of antenatal therapeutic synthetic glucocorticoids on the developing fetal brain.

Authors:  Melanie E Peffer; Janie Y Zhang; Leah Umfrey; Anthony C Rudine; A Paula Monaghan; Donald B DeFranco
Journal:  Mol Endocrinol       Date:  2015-03-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.